Intra-Cellular Therapies Inc. buy Bank of America Co.
Start price
29.03.23
/
50%
€52.40
Target price
29.03.24
€58.10
Performance (%)
22.14%
End price
30.03.24
€64.00
Summary
This prediction ended on 30.03.24 with a price of €64.00. The prediction had a final performance of 22.14%. Bank_of_America_Co_ has a follow-up prediction for Intra-Cellular Therapies Inc. where he still thinks Intra-Cellular Therapies Inc. is a Buy. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Intra-Cellular Therapies Inc. | -2.239% | -2.239% | 29.960% |
iShares Core DAX® | 2.147% | 2.681% | 17.410% |
iShares Nasdaq 100 | -0.578% | -0.816% | 24.107% |
iShares Nikkei 225® | 0.635% | 3.079% | 16.921% |
iShares S&P 500 | 0.746% | 0.171% | 23.802% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Bank of America Co. from $62.00 to $63.00. They now have a "buy" rating on the stock.
Ratings data for ITCI provided by MarketBeat
In the thread Trading Intra-Cellular Therapies Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€63.50
02.01.24
02.01.24
€74.81
02.01.25
02.01.25
4.72%
30.08.24
30.08.24
Stopped prediction by Bank_of_America_Co_ for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€68.50
18.04.24
18.04.24
€85.29
18.04.25
18.04.25
-2.92%
30.08.24
30.08.24